Mimedx (MDXG) Free Cash Flow (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.69% |
| Dec 31, 2025 | -15.33% |
| Sep 30, 2025 | 104.61% |
| Jun 30, 2025 | 189.31% |
| Mar 31, 2025 | -74.69% |
| Dec 31, 2024 | 5.00% |
| Sep 30, 2024 | -18.18% |
| Jun 30, 2024 | 368.33% |
| Mar 31, 2024 | -41.55% |
| Dec 31, 2023 | -39.74% |
| Sep 30, 2023 | 83.56% |
| Jun 30, 2023 | 259.71% |
| Mar 31, 2023 | -228.95% |
| Dec 31, 2022 | 495.08% |
| Sep 30, 2022 | 118.02% |
| Jun 30, 2022 | 67.27% |
| Mar 31, 2022 | 9.68% |
| Dec 31, 2021 | -297.98% |
| Sep 30, 2021 | 384.34% |
| Jun 30, 2021 | 113.85% |
| Mar 31, 2021 | 30.61% |
| Dec 31, 2020 | -135.71% |
| Sep 30, 2020 | -50.27% |
| Jun 30, 2020 | 73.62% |
| Mar 31, 2020 | 44.20% |
| Dec 31, 2019 | -618.31% |
| Sep 30, 2019 | -276.48% |
| Jun 30, 2019 | 111.81% |
| Mar 31, 2019 | -5,292.54% |
| Dec 31, 2018 | -121.88% |
| Sep 30, 2018 | -92.60% |
| Jun 30, 2018 | 156.32% |
| Mar 31, 2018 | -63.99% |
| Dec 31, 2017 | 41.30% |
| Sep 30, 2017 | 3.64% |
| Jun 30, 2017 | 26.79% |
| Mar 31, 2017 | -46.58% |
| Dec 31, 2016 | 1,431.95% |
| Sep 30, 2016 | -76.52% |
| Jun 30, 2016 | 285.36% |
| Mar 31, 2016 | -210.35% |
| Dec 31, 2015 | -52.08% |
| Sep 30, 2015 | 219.47% |
| Jun 30, 2015 | -38.28% |
| Mar 31, 2015 | -50.78% |
| Dec 31, 2014 | -34.79% |
| Sep 30, 2014 | 675.07% |
| Jun 30, 2014 | 169.97% |
| Mar 31, 2014 | -158.92% |
| Dec 31, 2013 | 261.01% |
| Sep 30, 2013 | 144.58% |
| Jun 30, 2013 | 20.12% |
| Mar 31, 2013 | -96.35% |
| Dec 31, 2012 | -7.83% |
| Sep 30, 2012 | -86.70% |
| Jun 30, 2012 | 57.35% |
| Mar 31, 2012 | 39.87% |
| Dec 31, 2011 | -126.37% |
| Sep 30, 2011 | 56.22% |
| Jun 30, 2011 | -13.64% |